New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
12:25 EDTFSLR, JASO, LDK, PC, DD, SPWR, TSL, ESLR, TEVA, GILD, STP, CSIQ, YGE, CRL, YMIOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday as investors wait on the Fed and other Washington powers to set the direction. The averages began the session slightly higher and have remained in a narrow range all morning. However, the day's real action may be yet to come, as investors await the conclusion of the two-day Federal Reserve policy meeting. The rate decision is due out at 12:30 pm ET. And, as always, headlines from Washington regarding the fiscal cliff negotiations are always a threat to swing the market quickly in either direction... ECONOMIC EVENTS: In the U.S., import prices fell more than expected and recorded their biggest drop in five months in November, dropping 0.9%. In Europe, the pace of contraction of industrial production in the 17 countries that use the euro accelerated in October, as activity fell 3.6% from a year ago compared to a contraction of 2.8% in September... COMPANY NEWS: DuPont (DD) shares rose 2% after the company said it expects its adjusted EPS to come in at the high end of its previous forecast and also authorized a repurchase program of $1B... A number of solar stocks moved up sharply amid numerous headlines from Chinese and Taiwanese media sources. Reports said China plans additional subsidies for solar companies there and also some China-based makers may sell solar cell equipment to Taiwan. A number of solar names moved higher, including Yingli Green Energy (YGE), up 20%, Trina Solar (TSL), also up 20%, and JA Solar (JASO), up 22%. Additionally, LDK Solar (LDK), which rose 27%, announced it has entered into discussions with certain creditors to obtain additional flexibility as it continues to work to address its previously disclosed liquidity and working capital concerns... MAJOR MOVERS: Among the notable gainers was Panasonic (PC), up almost 8% following an upgrade to Overweight at Barclays. Also higher were shares of YM BioSciences (YMI), up 77% after agreeing to be acquired by Gilead Sciences (GILD) for $2.95 per share in cash. Gilead shares, meanwhile, moved up 10c, or 0.13%. Among the noteworthy losers was Charles River Labs (CRL) down 8% after reaffirming its 2012 guidance and giving guidance for 2013 below Street expectations. Also lower were shares of Teva Pharmaceutical (TEVA), down 4.7% after Leerink downgraded the stock to Market Perform and Wells Fargo removed it from the firm's Priority Stock List... INDICES: Near noon, the Dow was up 8.25, or 0.06%, to 13,256.69; the Nasdaq was down 2.71, or 0.09%, to 3,019.59; and the S&P 500 was up 2.37, or 0.17%, to 1,430.21.
News For DD;YMI;GILD;PC;CRL;TEVA;LDK;YGE;ESLR;JASO;CSIQ;TSL;FSLR;STP;SPWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
June 19, 2015
08:02 EDTDDDuPont announces 'when-issued' trading of Chemours common stock
DuPont announced that, in connection with the separation of its Performance Chemicals segment through the planned spin-off of The Chemours Company on July 1, 2015, Chemours common stock will today begin "when-issued" trading on the New York Stock Exchange under the ticker symbol "CC WI". Chemours is expected to begin "regular way" trading on the New York Stock Exchange under the ticker symbol "CC" on July 1, 2015.
07:23 EDTTEVATeva data quite strong, says Bernstein
After Teva (TEVA) announced data for its TEV-48125 drug in episodic migraine, Bernstein notes that the drug met its primary and secondary endpoints. The firm says that the reduction in migraine days of Teva's drug appears to be higher than what Amgen (AMGN) and Lilly (LLY) have shown. The firm continues to see the migraine treatments from Teva and Alder as better than those from Lilly and Amgen.
07:02 EDTCSIQCanadian Solar receives $58M construction loan from Deutsche Bank
Subscribe for More Information
06:40 EDTGILDPatent linked to Gilead's Solvadi rejected by China, Reuters reports
Subscribe for More Information
June 18, 2015
17:05 EDTTEVANovartis announces U.S. launch of Glatopa
Sandoz, a Novartis (NVS) company, announced the U.S. launch of Glatopa, the first generic version of Teva's (TEVA) Copaxone 20 mg/ml one-time-daily multiple sclerosis therapy.
15:41 EDTTEVATeva tender offer for Mylan likely imminent, says Citi
Citi said Teva (TEVA) is likely to build up a 4.6% stake in Mylan (MYL) by today and that a formal tender offer is likely coming soon. An official bid could come with a provision requiring board changes and a tender will likely trigger a "poison pill" by Mylan, the firm added. Citi has a Buy rating and $70 price target on Teva shares.
12:51 EDTTEVATeva guidance assumed launch of Copaxone generic, says BMO Capital
Subscribe for More Information
11:57 EDTTEVAMylan comments on ruling by appeals court on Copaxone patent
Subscribe for More Information
11:54 EDTTEVAAppeals court invalidates Teva patent claim related to Copaxone
Subscribe for More Information
10:41 EDTTEVAMomenta reports CAFC decision to invalidated remanded Teva patent
Subscribe for More Information
09:11 EDTTEVAAlexza Pharmaceuticals amends Adasuve commercial partnership agreements
Subscribe for More Information
08:34 EDTTEVATeva to present new data from Phase 2b migraine prevention studies at AHS
Subscribe for More Information
08:02 EDTTEVATeva, Microchips Biotech announce partnership agreement
Subscribe for More Information
08:01 EDTSPWRSunPower starts construction on 102-megawatt Henrietta Solar Project
Subscribe for More Information
07:36 EDTGILD, TEVAReceptos remains an attractive takeover candidate, says Leerink
Subscribe for More Information
06:09 EDTTEVATeva raises stake in Mylan to 4.3%, Globes reports
Subscribe for More Information
June 17, 2015
17:45 EDTDDDuPont announces effectiveness of Chemours Company's Registration Statement
DuPont announced that the SEC has declared effective the Registration Statement on Form 10 of The Chemours Company. The Registration Statement on Form 10 includes information regarding the business and spin-off of Chemours, which is expected to be completed on July 1. In addition, on June 12, the NYSE authorized Chemours for listing on the exchange, with "regular way" trading to commence on July 1. As previously announced, on July 1, DuPont common stockholders will receive one share of common stock of Chemours for every five shares of DuPont common stock they hold on the record date. On June 19, it is expected that DuPont common stock on the NYSE will also trade "ex‑distribution" under the symbol "DD WI." Prior to July 1, shares of DuPont common stock that trade under "DD" will trade with the right to receive shares of Chemours common stock on July 1. Shares of DuPont common stock that trade under "DD WI" will trade without the right to receive shares of Chemours common stock. It is anticipated that "when-issued" trading on the NYSE in Chemours common stock will begin on June 19, under the symbol "CC WI." On July 1, Chemours common stock will begin "regular way" trading on the NYSE under the symbol "CC."
07:12 EDTTEVANeurocrine price target raised to $87 from $63 at Piper Jaffray
Subscribe for More Information
07:06 EDTCSIQCanadian Solar supplies modules for 42.9MW solar plant in Japan
Subscribe for More Information
06:32 EDTYGEYingli Green Energy announces partnership with LONGi
Yingli Green Energy announced that it has signed a framework agreement with Xi'an LONGi Silicon Materials to cooperatively manufacture monocrystalline silicon wafers, and ingots, solar cells and solar panels. The new partnership will help LONGi, the world's largest monocrystalline silicon manufacturer, expand into solar panel assembly while also enabling Yingli to integrate LONGi's highly competitive technology into its production lines. According to the agreement, the two parties will collaborate to employ their respective manufacturing capacities, technologies and resources across the full monocrystalline value chain, from monocrystalline ingots and wafers to solar cells and panels. For example, when producing ingots, Yingli will integrate LONGi's technology and cost-saving advantages into its own production lines, and LONGi will supply high quality monocrystalline wafers to Yingli at a competitive price. Under the same circumstances, Yingli agrees to preferentially procure LONGi's monocrystalline silicon wafers. In the meanwhile, both parties agreed to develop high-efficiency monocrystalline solar application markets from home and abroad and consider to use monocrystalline modules for their self-developed power plants, further to explore the possibilities to jointly develop monocrystalline silicon ingot plants.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use